Ir al contenido
· Rellenos dérmicos
SKU 11239

Yvoire Y-Solution 360

En stock
Volumen
1 x 1 mL
Laboratorio
LG Chem
Origen
Corea del Sur
Indicación
Anti-ageing correction with flexible projection
Zonas de tratamiento
El precio profesional y su historial son solo para cuentas verificadas
allpara suministra a profesionales autorizados. Inicie sesión o solicite una cuenta B2B para ver los precios en tiempo real, los tramos por volumen y el historial de precios.
Etiquetas

Yvoire Y-Solution 360 is a cross-linked hyaluronic acid dermal filler manufactured in South Korea as part of the YVOIRE Y-Solution range, which is built on a synergy between elasticity and cohesion that gives the gel spring-like characteristics for flexibility, projection and resistance to the dynamics of facial expression. The Y-Solution numbers are lift tiers rather than concentrations, and the 360 is the lightest gel in the entire Yvoire range. The product contains cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine and is intended for professional use by qualified practitioners only. It is supplied as a single 1 mL syringe with two Terumo thin-wall 29G needles enclosed; its shelf life is 17 months, shorter than the 24 months of the Classic, Volume and Contour references, so check the date when rotating stock.

Principales ventajas de Yvoire Y-Solution 360

  • Combines elasticity and cohesion, which the manufacturer describes as spring-like characteristics
  • Provides flexible projection and is designed to resist the dynamics of facial expression
  • Cross-linked hyaluronic acid at 12 mg/mL with 0.3% lidocaine, the lightest gel in the Yvoire range
  • Built on the manufacturer's S-HICE cross-linking process
  • Supports anti-ageing aesthetic treatment approaches
  • Part of the Y-Solution 360, 540 and 720 range, where the number is a lift tier rather than a concentration
  • Supplied with two Terumo thin-wall 29G needles
Información clave
Marca YVOIRE
Fabricante LG Chem
País de origen South Korea
Composición Cross-linked hyaluronic acid 12 mg/mL, lidocaine 0.3%
Envase 1 syringe x 1 mL with two Terumo thin-wall 29G needles enclosed
Tipo de uso Professional use only - injectable dermal filler with anaesthetic
Profundidad de inyección Facial skin layer

Indicaciones y uso profesional

Indicaciones principales

  • Anti-ageing aesthetic treatment
  • Facial projection support
  • Treatments requiring flexibility and cohesion

Uso profesional

Yvoire Y-Solution 360 is intended for administration by qualified medical practitioners trained in dermal filler injection technique, using aseptic technique. The manufacturer gives the application zone as the face and the injection site as the facial skin layer, and encloses two Terumo thin-wall 29G needles, a notably fine gauge that reflects a lighter gel than the Volume and Contour references in the range. This reference contains 0.3% lidocaine, so patients must be screened for sensitivity to amide-type local anaesthetics before treatment. Injection technique and volume per treatment area are determined by the practitioner.

Zonas de tratamiento

  • Face

Perfil del paciente

Suitable for adult patients seeking anti-ageing correction where flexibility and resistance to facial movement matter, as assessed by a qualified practitioner. At 12 mg/mL this is the lightest gel in the whole Yvoire range, well below the 20 to 22 mg/mL of the Volume and Contour references, so patients seeking structural contouring of the chin or nose, or correction of deep folds, are better served by those products. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates.

Cómo funciona Yvoire Y-Solution 360 ​

Yvoire Y-Solution 360 works through cross-linked hyaluronic acid at 12 mg/mL (1.2%), made by the manufacturer's S-HICE process and formulated for what it describes as a synergy between elasticity and cohesion. The intended effect is spring-like: the gel flexes with the face rather than resisting it, which is why the range is positioned around projection that survives the dynamics of facial expression rather than around static filling. At 12 mg/mL this is the lightest gel in the Yvoire range, against 20 to 22 mg/mL for the Volume and Contour references, and the two Terumo thin-wall 29G needles enclosed reflect that. The 0.3% lidocaine acts locally to improve comfort during injection.

Por qué comprar en Allpara

Allpara ofrece productos YVOIRE originales y verificados de proveedores seleccionados, con trazabilidad completa de lotes y asesoramiento experto. Atendemos a clínicas y profesionales de la estética con productos con certificado CE, entrega rápida en toda la UE desde nuestro almacén en la UE y precios profesionales competitivos. Nuestra prioridad es la seguridad, la satisfacción y los resultados de sus pacientes, con un servicio posventa dedicado para su tranquilidad.

Preguntas frecuentes

What is in Yvoire Y-Solution 360?

Cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine. Patients should be screened for sensitivity to amide-type local anaesthetics beforehand.

How does Yvoire Y-Solution 360 differ from the 540 and 720?

The 360 is 12 mg/mL with 29G needles. The 540 and 720 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, and are positioned at different lift levels rather than different concentrations. All three share the same elasticity and cohesion concept, and the numbers are lift tiers rather than concentrations.

/ Especificaciones

La ficha técnica

Categoría
Rellenos dérmicos
Marca
YVOIRE
Laboratorio
LG Chem
SKU
11239
Formato
1 x 1 mL
Origen
Corea del Sur
Indicación
Anti-ageing correction with flexible projection
Uso
Professional dermal filler with 0.3% lidocaine
Zonas de tratamiento
/ Detalles del producto

El expediente completo

Yvoire Y-Solution 360 is a cross-linked hyaluronic acid dermal filler manufactured in South Korea as part of the YVOIRE Y-Solution range, which is built on a synergy between elasticity and cohesion that gives the gel spring-like characteristics for flexibility, projection and resistance to the dynamics of facial expression. The Y-Solution numbers are lift tiers rather than concentrations, and the 360 is the lightest gel in the entire Yvoire range. The product contains cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine and is intended for professional use by qualified practitioners only. It is supplied as a single 1 mL syringe with two Terumo thin-wall 29G needles enclosed; its shelf life is 17 months, shorter than the 24 months of the Classic, Volume and Contour references, so check the date when rotating stock.

LG Chem, país de origen Corea del Sur.

Enviado a toda la UE desde nuestro almacén en la UE, con seguimiento y seguro, y envío en 24-72h. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote.

Conservar según las especificaciones del fabricante, protegido de la luz directa. La cadena de frío solo se utiliza cuando el producto lo requiere.

Condiciones de pago a 30 / 60 / 90 días* disponibles para cuentas verificadas previa aprobación de crédito. Se admite la facturación en EUR, CHF y GBP.

Las condiciones son orientativas y se confirman tras la revisión de la cuenta.

What is in Yvoire Y-Solution 360?

Cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine. Patients should be screened for sensitivity to amide-type local anaesthetics beforehand.

How does Yvoire Y-Solution 360 differ from the 540 and 720?

The 360 is 12 mg/mL with 29G needles. The 540 and 720 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, and are positioned at different lift levels rather than different concentrations. All three share the same elasticity and cohesion concept, and the numbers are lift tiers rather than concentrations.

/ Respuestas rápidas

Todo lo que un comprador pregunta primero

What is in Yvoire Y-Solution 360?
Cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine. Patients should be screened for sensitivity to amide-type local anaesthetics beforehand.
How does Yvoire Y-Solution 360 differ from the 540 and 720?
The 360 is 12 mg/mL with 29G needles. The 540 and 720 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, and are positioned at different lift levels rather than different concentrations. All three share the same elasticity and cohesion concept, and the numbers are lift tiers rather than concentrations.
/ FAQ

Preguntas frecuentes

Cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine. Patients should be screened for sensitivity to amide-type local anaesthetics beforehand.
The 360 is 12 mg/mL with 29G needles. The 540 and 720 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, and are positioned at different lift levels rather than different concentrations. All three share the same elasticity and cohesion concept, and the numbers are lift tiers rather than concentrations.

Más productos de LG Chem

Ver laboratorio

Alternativas para la clínica

Todos los productos

Yvoire Y-Solution 360

En stock
Precios solo para cuentas verificadas
Inicie sesión o solicite una cuenta B2B para ver su precio.
Solicitar cuenta B2B

Yvoire Y-Solution 360 is a cross-linked hyaluronic acid dermal filler manufactured in South Korea as part of the YVOIRE Y-Solution range, which is built on a synergy between elasticity and cohesion that gives the gel spring-like characteristics for flexibility, projection and resistance to the dynamics of facial expression. The Y-Solution numbers are lift tiers rather than concentrations, and the 360 is the lightest gel in the entire Yvoire range. The product contains cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine and is intended for professional use by qualified practitioners only. It is supplied as a single 1 mL syringe with two Terumo thin-wall 29G needles enclosed; its shelf life is 17 months, shorter than the 24 months of the Classic, Volume and Contour references, so check the date when rotating stock.

Principales ventajas de Yvoire Y-Solution 360

  • Combines elasticity and cohesion, which the manufacturer describes as spring-like characteristics
  • Provides flexible projection and is designed to resist the dynamics of facial expression
  • Cross-linked hyaluronic acid at 12 mg/mL with 0.3% lidocaine, the lightest gel in the Yvoire range
  • Built on the manufacturer's S-HICE cross-linking process
  • Supports anti-ageing aesthetic treatment approaches
  • Part of the Y-Solution 360, 540 and 720 range, where the number is a lift tier rather than a concentration
  • Supplied with two Terumo thin-wall 29G needles
Información clave
Marca YVOIRE
Fabricante LG Chem
País de origen South Korea
Composición Cross-linked hyaluronic acid 12 mg/mL, lidocaine 0.3%
Envase 1 syringe x 1 mL with two Terumo thin-wall 29G needles enclosed
Tipo de uso Professional use only - injectable dermal filler with anaesthetic
Profundidad de inyección Facial skin layer

Indicaciones y uso profesional

Indicaciones principales

  • Anti-ageing aesthetic treatment
  • Facial projection support
  • Treatments requiring flexibility and cohesion

Uso profesional

Yvoire Y-Solution 360 is intended for administration by qualified medical practitioners trained in dermal filler injection technique, using aseptic technique. The manufacturer gives the application zone as the face and the injection site as the facial skin layer, and encloses two Terumo thin-wall 29G needles, a notably fine gauge that reflects a lighter gel than the Volume and Contour references in the range. This reference contains 0.3% lidocaine, so patients must be screened for sensitivity to amide-type local anaesthetics before treatment. Injection technique and volume per treatment area are determined by the practitioner.

Zonas de tratamiento

  • Face

Perfil del paciente

Suitable for adult patients seeking anti-ageing correction where flexibility and resistance to facial movement matter, as assessed by a qualified practitioner. At 12 mg/mL this is the lightest gel in the whole Yvoire range, well below the 20 to 22 mg/mL of the Volume and Contour references, so patients seeking structural contouring of the chin or nose, or correction of deep folds, are better served by those products. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates.

Cómo funciona Yvoire Y-Solution 360 ​

Yvoire Y-Solution 360 works through cross-linked hyaluronic acid at 12 mg/mL (1.2%), made by the manufacturer's S-HICE process and formulated for what it describes as a synergy between elasticity and cohesion. The intended effect is spring-like: the gel flexes with the face rather than resisting it, which is why the range is positioned around projection that survives the dynamics of facial expression rather than around static filling. At 12 mg/mL this is the lightest gel in the Yvoire range, against 20 to 22 mg/mL for the Volume and Contour references, and the two Terumo thin-wall 29G needles enclosed reflect that. The 0.3% lidocaine acts locally to improve comfort during injection.

Por qué comprar en Allpara

Allpara ofrece productos YVOIRE originales y verificados, con trazabilidad completa de lotes, stock con certificado CE, entrega rápida en toda la UE y servicio posventa experto.

Preguntas frecuentes

What is in Yvoire Y-Solution 360?

Cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine. Patients should be screened for sensitivity to amide-type local anaesthetics beforehand.

How does Yvoire Y-Solution 360 differ from the 540 and 720?

The 360 is 12 mg/mL with 29G needles. The 540 and 720 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, and are positioned at different lift levels rather than different concentrations. All three share the same elasticity and cohesion concept, and the numbers are lift tiers rather than concentrations.

Más productos de LG Chem

Ver el laboratorio →

Yvoire Y-Solution 360 is a cross-linked hyaluronic acid dermal filler manufactured in South Korea as part of the YVOIRE Y-Solution range, which is built on a synergy between elasticity and cohesion that gives the gel spring-like characteristics for flexibility, projection and resistance to the dynamics of facial expression. The Y-Solution numbers are lift tiers rather than concentrations, and the 360 is the lightest gel in the entire Yvoire range. The product contains cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine and is intended for professional use by qualified practitioners only. It is supplied as a single 1 mL syringe with two Terumo thin-wall 29G needles enclosed; its shelf life is 17 months, shorter than the 24 months of the Classic, Volume and Contour references, so check the date when rotating stock.

LG Chem, país de origen Corea del Sur.

Enviado a toda la UE desde nuestro almacén en la UE, envío en 24-72h, con seguimiento y seguro. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote. Conservar según las especificaciones del fabricante.

Pago a 30 / 60 / 90 días* para cuentas verificadas previa aprobación de crédito. Facturación en EUR, CHF y GBP.

What is in Yvoire Y-Solution 360?

Cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine. Patients should be screened for sensitivity to amide-type local anaesthetics beforehand.

How does Yvoire Y-Solution 360 differ from the 540 and 720?

The 360 is 12 mg/mL with 29G needles. The 540 and 720 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, and are positioned at different lift levels rather than different concentrations. All three share the same elasticity and cohesion concept, and the numbers are lift tiers rather than concentrations.

* Producto de uso profesional. El envase puede variar según el lote o el mercado. Consulte las instrucciones de uso suministradas para las indicaciones completas y las contraindicaciones.